Anne Holmes is the first person in New Mexico to join a phase 3 clinical trial that tests a personalized vaccine for metastatic kidney cancer.
Read the story the press release about the trial and about Ms. Holmes' treatment. Also read the Albuquerque Business First article by Sal Christ.
Anne Holmes prepares to receive an injection of her personalized kidney cancer vaccine
Tags: clinical research, clinical trial, General Renal Cancer, In the News Archive, kidney cancer, metastatic, Renal (Kidney) Cancer, Renal Cancer
